市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 看跌 | 看跌 |
| Health Information Services (全球的) | 看跌 | 看跌 | |
| 股票 | Aclarion Inc | - | - |
AIStockmoo 评分
-0.7
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | NA |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.0 |
| 平均 | -0.67 |
|
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合